Ayurveda Meets Traditional Chinese Medicine: How BRICS Is Standardising Alternative Healthcare Systems Globally

BRICS is moving traditional, complementary, and integrative medicine from cultural exchange into a more formal health-policy conversation. The goal is not to make Ayurveda, Traditional Chinese Medicine, herbal remedies, yoga, acupuncture, or other wellness therapies identical, but to create shared expectations for evidence, safety, quality, research, and responsible integration into health systems. In 2026, BRICS leaders welcomed a proposed Expert Working Group on Traditional, Complementary and Integrative Medicine, while WHO’s current global strategy is pushing countries towards evidence-informed, culturally respectful integration.

What Does Standardisation Mean for Alternative Healthcare Systems?

Standardisation means creating common rules for how alternative healthcare systems are studied, documented, regulated, taught, and monitored. It does not mean turning Ayurveda into Traditional Chinese Medicine or replacing biomedical care with natural healing methods. In the BRICS context, standardisation is more about building bridges: shared research methods, better product quality checks, stronger pharmacovigilance, clearer practitioner training expectations, and safer ways to combine complementary medicine with mainstream healthcare.

That distinction matters. Traditional systems often rely on individualised assessment, local ingredients, philosophical frameworks, and long-practised clinical traditions. A rigid one-size-fits-all model could flatten that diversity. A useful standard, by contrast, protects what makes each tradition distinctive while making it easier for regulators, researchers, clinicians, and patients to ask practical questions: What is being used? Who is qualified to provide it? What is the evidence? What are the risks? How should outcomes be tracked?

Useful standardisation can include:

• Shared terminology so researchers and regulators know whether they are discussing a herb, a preparation, a diagnostic concept, a procedure, or a lifestyle practice.
• Quality standards for products that address identity, purity, contamination, consistency, storage, and labelling.
• Research protocols that allow multi-country studies without ignoring the individualised nature of many alternative therapies.
• Training benchmarks that help define minimum knowledge, ethics, safety, and referral responsibilities for practitioners.
• Digital registries and databases that support clinical trials, adverse-event reporting, and access to traditional knowledge while respecting national laws and community rights.

BRICS Has Become a Testing Ground for Coordinated Traditional Medicine Policy

BRICS is well suited to this conversation because several of its members have large populations, deep traditional medicine histories, growing health-technology ambitions, and strong interest in affordable care. India brings Ayurveda, Siddha, Unani, yoga, and other AYUSH systems into the discussion. China brings Traditional Chinese Medicine, including herbal formulas, acupuncture, tai chi, and related practices. Other BRICS members and partners bring their own herbal, indigenous, and community-based healing traditions.

The policy momentum became more visible in July 2026, when India hosted BRICS health-track meetings in Chandigarh. The 16th BRICS Health Ministers’ Meeting included a dedicated focus on traditional, complementary, and integrative medicine, and WHO described the outcome as the strongest political recognition of traditional medicine in BRICS health cooperation so far. The declaration supported cooperation on research, clinical validation, toxicity assessment, pharmacovigilance, quality, safety, digital knowledge platforms, and AI-related applications.

At the September 2026 BRICS Summit in New Delhi, leaders again acknowledged the relevance of traditional, complementary, and integrative medicine to Universal Health Coverage. They welcomed the proposed BRICS Expert Working Group on TCIM and highlighted coordinated research on medicinal plants and herbal preparations, while emphasising quality, safety, efficacy, evidence-informed approaches, and regulatory frameworks aligned with national contexts.

Ayurveda and Traditional Chinese Medicine Show Both the Promise and the Challenge

Ayurveda and Traditional Chinese Medicine are often discussed together because both are comprehensive systems rather than single treatments. Each includes theories of health and imbalance, dietary and lifestyle guidance, herbal remedies, practitioner training traditions, and mind-body healing practices. Both also attract global consumer interest, from wellness retreats and supplements to clinical services and digital health platforms.

Yet they are not interchangeable. Ayurveda may frame care around concepts such as dosha balance, digestion, daily routine, seasonal living, and individualised constitution. Traditional Chinese Medicine may frame care around patterns, qi, yin-yang relationships, meridians, organ systems, and formula-based herbal strategies. Standardisation becomes difficult because the same modern diagnosis may be interpreted differently within each system, and the same traditional intervention may be customised for different people.

That is why BRICS-style cooperation is likely to focus less on forcing diagnostic sameness and more on practical safeguards. A turmeric product, a complex TCM formula, a yoga-based intervention, or an acupuncture protocol can be documented, tested, labelled, and monitored more consistently without erasing the tradition behind it. The strongest model is not ‘traditional versus modern’, but ‘traditional knowledge plus modern accountability’.

Why Is Evidence Such a Central Issue?

Evidence is central because global acceptance depends on whether alternative therapies can be evaluated for benefits, risks, appropriate use, and limits. WHO’s Global Traditional Medicine Strategy 2025–2034 focuses on evidence, safety, quality, effectiveness, integration where appropriate, and cross-sector collaboration; it explicitly does not position traditional medicine as preferable to biomedical care.

This creates a more mature conversation than either blind rejection or uncritical promotion. Many people use wellness therapies because they want prevention, whole-person care, cultural continuity, fewer fragmented appointments, or support for stress, sleep, pain, digestion, or lifestyle change. Those motivations are real. But public health systems need more than popularity: they need reliable data, practitioner accountability, and ways to detect harm.

Evidence-building for natural healing methods may require several approaches:

1. Classical clinical trials for defined products, standardised extracts, or clearly described interventions.
2. Pragmatic real-world studies that observe how treatments are used in actual clinics.
3. Comparative research that evaluates when a complementary approach may add value alongside usual care.
4. Safety surveillance that tracks adverse events, contamination, incorrect use, and herb-drug interactions.
5. Implementation research that studies how services can be integrated into primary care without delaying necessary diagnosis or treatment.

The best evidence agenda should also admit uncertainty. Some practices may prove useful for specific purposes. Some may require tighter regulation. Similarly, some may not hold up under careful study. A credible system can handle all three outcomes.

Safety Standards Protect Patients and Credible Practitioners

Safety is where standardisation becomes immediately practical. Herbal remedies can vary by plant species, growing region, harvesting method, preparation, dose, and manufacturing quality. Supplements and herbal products may also interact with prescription medicines, and US guidance warns consumers not to substitute dietary supplements for prescribed medicine or assume they were approved for safety and effectiveness before sale.

For patients, this means ‘natural’ should not be treated as a synonym for ‘risk-free’. For practitioners, it means good documentation and referral habits are part of ethical care. Similarly, for regulators, it means quality control is not bureaucracy for its own sake; it is the difference between a transparent therapeutic product and an unpredictable marketplace.

A sensible patient-safety checklist includes:

• Tell your physician, pharmacist, and traditional medicine practitioner about all medicines, supplements, and herbs you use.
• Be especially cautious if you are pregnant, nursing, managing cancer, using blood thinners, taking immune-suppressing drugs, or treating a serious chronic condition.
• Avoid products that promise guaranteed cures, instant reversal of disease, or secret formulas.
• Look for clear labelling, ingredient disclosure, batch information, and quality testing where available.
• Use complementary medicine as a complement, not a reason to delay urgent or evidence-based medical care.

Digital Health May Accelerate Global Coordination

One of the most important BRICS signals is the attention to digital platforms, repositories, databases, interoperability, and AI. This may sound technical, but it affects everyday healthcare. If countries can document traditional medicine practices in comparable formats, researchers can find patterns, regulators can monitor safety signals, and practitioners can learn from broader evidence rather than isolated experience.

Digital tools could also help preserve knowledge that might otherwise remain fragmented or inaccessible. Traditional medicine is often held in texts, oral lineages, regional languages, local practice, and community memory. Responsible digitisation can support education and research, but it must also respect intellectual property, Indigenous rights, biodiversity, and benefit-sharing.

The risk is that technology could oversimplify complex healing traditions into searchable product claims. The opportunity is better: digital infrastructure can make traditional medicine more transparent, traceable, and research-ready while keeping cultural context visible.

The Future Is Integrative, but Not Automatic

The global future of alternative healthcare systems will depend on trust. Patients need confidence that products are safe, practitioners are qualified, and claims are honest. Clinicians need reliable information about interactions, referrals, and appropriate use. Governments need frameworks that expand access without lowering standards.

BRICS is not creating a single global licence for Ayurveda, Traditional Chinese Medicine, or every form of complementary medicine. It is helping build a policy architecture where ancient systems can be discussed in modern regulatory language: evidence, safety, efficacy, quality, access, sustainability, and digital cooperation. If that work succeeds, the biggest benefit will not be branding. It will be a safer, clearer, and more accountable path for people who already use herbal remedies, mind-body healing, and wellness therapies as part of their health lives.

The key takeaway is simple: standardisation should not strip traditional medicine of its identity. Done well, it can protect patients, support credible practitioners, improve research, and help natural healing methods earn an appropriate place in evidence-informed healthcare.

Also Read: Preventing Famine: How The BRICS Grain Exchange Could Stabilise Global Wheat And Food Prices During Crises